Format

Send to

Choose Destination
Br J Radiol. 2019 Jun;92(1098):20190059. doi: 10.1259/bjr.20190059. Epub 2019 May 8.

Utilization of volumetric magnetic resonance imaging for baseline and surveillance imaging in Neuro-oncology.

Author information

1
1 Department of Neuroradiology, The Walton Centre NHS Foundation Trust , Liverpool , United Kingdom.
2
2 National Cancer Research Institute Metastases and Meningioma subgroup of the Brain Clinical Studies Group , London , United Kingdom.
3
3 Cancer Research UK Cambridge Centre , Cambridge , United Kingdom.
4
4 Institute of Translational and Stratified Medicine, Peninsula Schools of Medicine and Dentistry , Plymouth , United Kingdom.
5
5 Department of Clinical Oncology, The Newcastle upon Tyne Hospitals NHS Foundation Trust , Newcastle , United Kingdom.
6
6 Department of Neurosurgery, Queens Hospital , Romford , England.
7
7 Department of Oncology, University Hospitals Birmingham NHS Foundation Trust , Birmingham , United Kingdom.
8
8 Department of Neurosurgery, Cambridge University Hospitals NHS Foundation Trust , Cambridge , United Kingdom.
9
9 Department of Clinical Oncology, The Christie NHS Foundation Trust , Manchester , United Kingdom.
10
10 Department of Neurosurgery, The Walton Centre NHS Foundation Trust , Liverpool , United Kingdom.

Abstract

The acquisition of volumetric post-contrast MRI has clear advantages in the interpretation of neuro-oncology studies but has yet to find its way into routine clinical practice beyond planning scans for surgery and radiotherapy. This commentary briefly highlights the benefits of these techniques whilst dispelling some of the perceived disadvantages.

PMID:
30924680
PMCID:
PMC6592091
[Available on 2020-06-01]
DOI:
10.1259/bjr.20190059
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center